Oppenheimer’s Favorite Stocks For Next 12 Months: Top 32 Stock Picks

25. TransMedics Group, Inc. (NASDAQ:TMDX)

Share Price Upside: 3%

Number of Hedge Fund Investors In Q2 2024: 29

Average Analyst Share Price Target: $180.25

TransMedics Group, Inc. (NASDAQ:TMDX) is one of the more interesting health care stocks that you’re likely to come across. This is because it is an organ transplant services provider that enables the preservation of the liver, heart, and lungs that are destined for transportation. TransMedics Group, Inc. (NASDAQ:TMDX) augments this business specialty by also providing a robust logistics network that also includes air assets which are key as transplant surgeries often require fast organ transportation in order to save patients’ lives. TransMedics Group, Inc. (NASDAQ:TMDX)’s focus on organ donation also means that it stands to benefit from a sizeable market that will only grow in the future especially when medical science further expands the use of animal organs in humans. TransMedics Group, Inc. (NASDAQ:TMDX)’s market was validated recently when a Swedish firm announced that it would acquire a peer donation company for a hefty $477 million price tag – indicating that firms are willing to fork out substantial amounts for similar businesses. As for the firm’s industry leading OCS system, Oppenheimer shares that it “represents a disruptive technology that could potentially revolutionize solid organ preservation and transport.”

Headwaters Capital Management mentioned TransMedics Group, Inc. (NASDAQ:TMDX) in its Q2 2024 investor letter. Here is what the firm said:

“TransMedics (TMDX) +104%: TransMedics posted strong first quarter results and raised full year revenue guidance. The results were validation of the Company’s strategy to own and operate an internal logistics fleet to drive increased adoption of their revolutionary organ care system. Market penetration in each organ (liver, heart and lung) remains low and when combined with the potential to grow the overall market should support strong revenue growth for the company for many years.”